Validity and reliability of strain gauge measurement of volitional quadriceps force in patients with COPD


Rodrigues F. M., DEMEYER H., HORNIKX M., CAMILLO C. A., Calik-Kutukcu E., BURTIN C., ...Daha Fazla

CHRONIC RESPIRATORY DISEASE, cilt.14, sa.3, ss.289-297, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1177/1479972316687210
  • Dergi Adı: CHRONIC RESPIRATORY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.289-297
  • Hacettepe Üniversitesi Adresli: Evet

Özet

This study investigated the validity and reliability of fixed strain gauge measurements of isometric quadriceps force in patients with chronic obstructive pulmonary disease (COPD). A total cohort of 138 patients with COPD were assessed. To determine validity, maximal volitional quadriceps force was evaluated during isometric maximal voluntary contraction (MVC) manoeuvre via a fixed strain gauge dynamometer and compared to (a) potentiated non-volitional quadriceps force obtained via magnetic stimulation of the femoral nerve (twitch (Tw); n = 92) and (b) volitional computerized dynamometry (Biodex; n = 46) and analysed via correlation coefficients. Test-retest and absolute reliability were determined via calculations of intra-class correlation coefficients (ICCs), smallest real differences (SRDs) and standard errors of measurement (SEMs). For this, MVC recordings in each device were performed across two test sessions separated by a period of 7 days (n = 46). Strain gauge measures of MVC demonstrated very large correlation with Tw and Biodex results (r = 0.86 and 0.88, respectively, both p < 0.0001). ICC, SEM and SRD were numerically comparable between strain gauge and Biodex devices (ICC = 0.96 vs. 0.93; SEM = 8.50 vs. 10.54 Nm and SRD = 23.59 vs. 29.22 Nm, respectively). The results support that strain gauge measures of quadriceps force are valid and reliable in patients with COPD.